Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes.
Eran AshwalJohannes KeunenAnjana RavichandranKatie EllulSwati AgrawalSebastian R HobsonRory C WindrimJohn C KingdomPublished in: Prenatal diagnosis (2023)
In pregnancies with unexplained abnormal first-trimester biomarkers, mid-trimester PlGF outperformed a comprehensive ultrasound assessment in the identification of a subset of patients destined to develop placental dysfunction. This blood test may be an alternative initial approach in this context, especially where access to specialist care is more geographically challenging.
Keyphrases
- growth factor
- palliative care
- end stage renal disease
- pregnancy outcomes
- ejection fraction
- prognostic factors
- peritoneal dialysis
- oxidative stress
- gestational age
- patient reported outcomes
- computed tomography
- quality improvement
- pregnant women
- pain management
- chronic pain
- weight loss
- patient reported
- clinical evaluation
- optic nerve